IRIS
POGGIO, FRANCESCA BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.892
AS - Asia 776
NA - Nord America 741
Continente sconosciuto - Info sul continente non disponibili 189
SA - Sud America 78
AF - Africa 14
Totale 6.690
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.736
US - Stati Uniti d'America 679
SG - Singapore 280
CN - Cina 193
VN - Vietnam 135
BD - Bangladesh 89
FR - Francia 41
BR - Brasile 35
FI - Finlandia 35
HK - Hong Kong 32
DE - Germania 31
CA - Canada 21
AR - Argentina 15
GB - Regno Unito 11
JP - Giappone 11
MX - Messico 11
EC - Ecuador 8
JM - Giamaica 7
ES - Italia 6
IN - India 6
NL - Olanda 6
PY - Paraguay 6
CO - Colombia 5
NI - Nicaragua 5
AT - Austria 4
DZ - Algeria 4
ID - Indonesia 4
RU - Federazione Russa 4
VE - Venezuela 4
HN - Honduras 3
IQ - Iraq 3
KE - Kenya 3
PE - Perù 3
RO - Romania 3
SV - El Salvador 3
BE - Belgio 2
BS - Bahamas 2
CH - Svizzera 2
CR - Costa Rica 2
IE - Irlanda 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PR - Porto Rico 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UA - Ucraina 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GP - Guadalupe 1
GT - Guatemala 1
IL - Israele 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MR - Mauritania 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 6.501
Salva come PNG Salva come JPEG
Città #
Genoa 1.943
Genova 1.853
Rapallo 404
Vado Ligure 388
San Jose 160
Singapore 140
Ashburn 68
Beijing 44
Council Bluffs 44
Ho Chi Minh City 44
Lauterbourg 35
Santa Clara 34
New York 33
Helsinki 31
Hanoi 30
Hong Kong 29
Bordighera 22
Frankfurt am Main 18
Milan 14
Buffalo 13
Los Angeles 11
Boardman 10
Catania 10
Orem 9
Rome 9
Tokyo 9
Mexico City 8
São Paulo 8
Toronto 8
Agawam 7
Haiphong 7
Kingston 7
Shenzhen 6
Atlanta 5
Chicago 5
Dallas 5
Florence 5
Managua 5
Schiffdorf 5
Seattle 5
Bologna 4
Boston 4
Brescia 4
City of London 4
Da Nang 4
Hải Dương 4
Lappeenranta 4
Madrid 4
Miami 4
Newark 4
Ninh Bình 4
Philadelphia 4
Tianjin 4
Asunción 3
Brasília 3
Brooklyn 3
Curitiba 3
Detroit 3
El Paso 3
Gallarate 3
Las Vegas 3
Montreal 3
Mount Vernon 3
Muggia 3
Naples 3
North Bergen 3
Orlando 3
Paris 3
Phủ Lý 3
Piscataway 3
Quito 3
San Francisco 3
Stuttgart 3
Verona 3
Vienna 3
Washington 3
Afragola 2
Amenia 2
Amsterdam 2
Asheville 2
Biên Hòa 2
Brussels 2
Changsha 2
Columbus 2
Córdoba 2
Dayton 2
Dublin 2
Greenville 2
Guayaquil 2
Gurugram 2
Hamilton 2
Hartford 2
Houston 2
Huntsville 2
Kaunakakai 2
London 2
Louisville 2
Monroe 2
Nasiriyah 2
Nassau 2
Totale 5.660
Salva come PNG Salva come JPEG
Nome #
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis 227
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 208
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 208
Management of young women with early breast cancer 192
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of Fc gamma RIIIA/Fc gamma RIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 182
Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient–level data 182
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 179
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 179
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 177
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 169
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 168
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 168
News on the medical treatment of young women with early-stage HER2-negative breast cancer 167
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 165
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients 165
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 165
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials 163
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 162
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis 158
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 154
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 151
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 150
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer 148
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 143
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 143
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 141
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 137
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects 136
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 132
Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do? 130
Role of dose-dense chemotherapy in high-risk early breast cancer 128
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 126
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world 117
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper" 106
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria 105
Fertility counseling of young breast cancer patients 104
Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis 102
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies 98
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered? 98
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 94
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 92
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 90
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study 86
Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: (ESMO Open (2021) 6(2), (S2059702921000089), (10.1016/j.esmoop.2021.100054)) 83
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 80
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial 73
Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report 68
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies 57
null 27
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial 7
Totale 6.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.171
article - articoli 22.171
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022403 15 16 26 50 14 43 10 86 42 39 12 50
2022/2023478 46 51 6 54 71 73 10 38 68 2 57 2
2023/2024287 11 29 4 49 23 21 23 20 15 18 23 51
2024/20251.236 45 74 27 57 134 138 123 250 77 68 125 118
2025/20262.513 255 112 305 197 291 137 326 121 168 248 144 209
2026/2027195 195 0 0 0 0 0 0 0 0 0 0 0
Totale 6.690